Article
Mutant SOD1 instability: implications for toxicity in amyotrophic lateral sclerosis.
Neuro-degenerative diseases - 1 Jan 2005
Tiwari Ashutosh, Hayward Lawrence J
Abstract excerpt
The biological basis of preferential motor neuron degeneration in amyotrophic lateral sclerosis (ALS) remains incompletely understood, and effective therapies to prevent the lethal consequences of this disorder are not yet available. Since 1993, more than 100 mutant variants of the antioxidant enzyme Cu/Zn superoxide dismutase (SOD1) have been identified in familial ALS. Many studies have sought to distinguish...
Topics
- Amyotrophic Lateral Sclerosis
- Animals
- Humans
- Mutation
- Protein Structure, Quaternary
- Superoxide Dismutase
- Superoxide Dismutase-1
